JPMorgan Chase & Co. Issues Positive Forecast for Molina Healthcare (NYSE:MOH) Stock Price

Molina Healthcare (NYSE:MOH) had its target price raised by stock analysts at JPMorgan Chase & Co. from $169.00 to $191.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential downside of 3.13% from the company’s current price.

Several other brokerages have also recently issued reports on MOH. TD Cowen dropped their price target on Molina Healthcare from $175.00 to $144.00 and set a “hold” rating on the stock in a research report on Monday, February 9th. Bank of America upgraded Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price for the company in a research note on Wednesday, April 29th. Mizuho set a $215.00 target price on Molina Healthcare in a research note on Monday. Cantor Fitzgerald upped their target price on Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Finally, Wells Fargo & Company upped their target price on Molina Healthcare from $141.00 to $159.00 and gave the company an “equal weight” rating in a research note on Monday, April 27th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $182.73.

Molina Healthcare Trading Up 3.3%

Molina Healthcare stock traded up $6.31 during trading on Monday, reaching $197.17. 159,551 shares of the company were exchanged, compared to its average volume of 1,567,760. The stock’s 50 day simple moving average is $168.40 and its two-hundred day simple moving average is $162.57. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The company has a market capitalization of $10.27 billion, a P/E ratio of 58.26 and a beta of 0.80. Molina Healthcare has a 52-week low of $121.06 and a 52-week high of $311.52.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. During the same quarter last year, the firm earned $6.08 earnings per share. The firm’s quarterly revenue was down 3.1% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, equities research analysts expect that Molina Healthcare will post 5.23 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of Molina Healthcare stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Torren Management LLC acquired a new position in shares of Molina Healthcare during the fourth quarter worth about $26,000. Miller Global Investments LLC acquired a new stake in shares of Molina Healthcare in the fourth quarter valued at $27,000. Physician Wealth Advisors Inc. boosted its stake in shares of Molina Healthcare by 1,250.0% during the 1st quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock worth $29,000 after acquiring an additional 200 shares in the last quarter. Cromwell Holdings LLC raised its holdings in shares of Molina Healthcare by 211.9% during the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after acquiring an additional 125 shares in the last quarter. Finally, Quarry LP purchased a new stake in shares of Molina Healthcare during the fourth quarter worth $32,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.